Why You Should Think Twice About Neulasta Or Neupogen When On Chemotherapy
By Donnie Yance
“The most telling and profound way of describing the evolution of the universe would undoubtedly be to trace the evolution of love.” ― Pierre Teilhard de Chardin
Introduction
Cancer patients frequently experience weakened immune systems from both their tumor burden and aggressive conventional treatments. While medical advances like colony-stimulating factors and erythropoietin have helped address some complications from chemotherapy and radiation treatments, these solutions often provide only temporary relief from long-term immune system damage in both clinical and outpatient contexts.
Research has demonstrated that controlled endotoxin exposure can significantly boost immunity in immunocompromised cancer patients and other vulnerable populations by counteracting the suppression of the immune system by viruses. However, this presents a complex challenge, as cytotoxic cancer treatments typically cause prolonged suppression of the immune system, which increases patients’ vulnerability to secondary cancers and other complications.
Continue reading “Secret Dangers Of Neulasta Or Neupogen When On Chemotherapy”